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Abstract We report the isolation of a cDNA clone named
GPR54, which encodes a novel G protein-coupled receptor
(GPCR). A PCR search of rat brain cDNA retrieved a clone
partially encoding a GPCR. In a library screening this clone was
used to isolate a cDNA with an open reading frame (ORF)
encoding a receptor of 396 amino acids long which shared
significant identities in the transmembrane regions with rat
galanin receptors GalR1 (45%), GalR3 (45%) and GalR2 (44%).
Northern blot and in situ hybridization analyses revealed that
GPR54 is expressed in brain regions (pons, midbrain, thalamus,
hypothalamus, hippocampus, amygdala, cortex, frontal cortex,
and striatum) as well as peripheral regions (liver and intestine).
In COS cell expression of GPR54 no specific binding was
observed for 125I-galanin. A recent BLAST search with the rat
GPR54 ORF nucleotide sequence recovered the human ortholo-
gue of GPR54 in a 3.5 Mb contig localized to chromosome
19p13.3.
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1. Introduction
Galanin is a 29^30 amino acid (aa) neuropeptide which is
not a member of any known family of neuropeptides [1].
Galanin is expressed in both the central and peripheral nerv-
ous systems and modulates a wide variety of physiological
processes including learning and memory [2], nociception [3],
feeding [4], neurotransmitter and hormone release [5^7], and
sexual behavior [8], and is considered to be involved in the
pathogenesis of Alzheimer’s disease [9]. The e¡ects of galanin
are mediated through at least three G protein-coupled recep-
tors (GPCR), GalR1 [10], GalR2 [11], and GalR3 [12]. To
date we have identi¢ed two human galanin receptors, GalR2
and GalR3 [13], both with distinct pharmacological pro¢les
and tissue expression patterns. We now report a novel cDNA
and gene GPR54, which encodes the closest known relative to
the galanin receptor gene family.
2. Materials and methods
2.1. PCR ampli¢cation and cDNA library screening
A rat brain 5P Stretch cDNA library (Clontech) and human ge-
nomic DNA were ampli¢ed by the polymerase chain reaction (PCR)
using proofreading Pfu polymerase (Stratagene) and degenerate oli-
gonucleotides based upon sequences encoding GPCR conserved trans-
membrane (TM) regions 3 (P1: 5P-CTGACCGGCATGABDETF-
GADCGHTA-3P ; B = C or G, D = C or T, E = A or G or T, F = C
or G or T, H = A or C, I = A or C or G or T, J = A or C or G, K = A
or G) and 7 (P2: 5P-GAAGGCGTAGAFBAIJGGKTT). PCR con-
ditions were as follows: denaturation at 94‡C for 30 s, annealing at
55, 48, 45, 42, or 40‡C for 40 s, and extension at 72‡C for 30 s, for
30 cycles, followed by a 7 min extension at 72‡C. The PCR products
were extracted with phenol/chloroform, precipitated with ethanol and
electrophoresed on a low melting point agarose gel. PCR product
bands in the expected size range were excised from the gel, ligated
into the EcoRV site of pBluescript SK3 (Stratagene) and sequenced.
One insert appeared to encode a novel GPCR and was labeled with
[32P]dCTP-K (NEN) by nick translation (Amersham) and used to
screen the same library ampli¢ed above as previously described [14].
Positive phage clones were plaque puri¢ed and their inserts ampli¢ed
by PCR using Pfu polymerase and primers £anking the Vgt11 EcoRI
cloning site. The PCR products were blunt-end ligated into the
EcoRV site of pBluescript SK3 (Stratagene) and sequenced on both
strands.
2.2. Northern blot analysis
Rat mRNAs from several rat tissues were extracted as described
previously [14]. Brie£y, total RNA was extracted by the method of
Chomczynski and Sacci [15] and poly(A) RNA isolated using oli-
go(dT) cellulose spin columns (Pharmacia, Uppsala, Sweden). RNA
was denatured and size fractionated on a 1% formaldehyde agarose
gel, transferred onto nylon membrane and immobilized by UV irra-
diation. The blots were hybridized with a 32P-labeled DNA fragment
encoding GPR54, washed with 2USSPE and 0.1% SDS at 50‡C for
20 min and again with 0.1USSPE and 0.1% SDS at 50‡C for 2 h and
exposed to X-ray ¢lm at 370‡C in the presence of an intensifying
screen.
2.3. In situ hybridization analysis
A 35S-labeled DNA fragment encoding GPR54 was used as a probe
for in situ hybridization. Preparation of rat brain sections and in situ
hybridization procedures were done as previously described [16].
2.4. Expression of GPR54 cDNA in COS-7 mammalian cells
The African green monkey SV40 transformed kidney cell line (COS-
7 cells), obtained from the American Type Culture Collection, was
grown in Dulbecco’s modi¢ed Eagle’s medium supplemented with
10% heat-inactivated fetal calf serum (Sigma), 50 U/ml penicillin,
50 Wg/ml streptomycin (Flow Laboratories, McLean, VA), and
2 mM glutamine (Flow Laboratories) at 37‡C under an atmosphere
of 6% CO2. 5U106 cells per 175 cm2 culture £ask were seeded in 20 ml
of media and transiently transfected at 80% con£uence with either
2.75, 5.5, or 11.65 Wg of pcDNA3-GPR54 or pcIneo-hGALR1 plas-
mids and 70 Wl of LipofectAMINE reagent (Life Technologies, Inc.),
following recommendations of the manufacturer. Two days after
transfection, cells were harvested following dissociation in enzyme-
free dissociation solution (Specialty Media, Lavallette, NJ).
2.5. Membrane preparation and radioligand binding assays
Membranes were prepared from transfected cells by disruption by
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pressurized nitrogen cavitation in ice-cold membrane bu¡er (10 mM
Tris, pH 7.4, 10 mM phenylmethylsulfonyl £uoride, 10 mM phos-
phoramidon). After a low speed (1100Ug for 10 min at 4‡C) and a
high speed centrifugation (38 700Ug for 15 min at 4‡C), membranes
were resuspended in bu¡er and their protein concentration determined
(Bio-Rad assay kit). Binding of 125I-human galanin (speci¢c activity of
2200 Ci/mmol, DuPont NEN) was measured in membranes using a
bu¡er of 25 mM Tris, pH 7.4, 0.3% BSA, 2 mM MgCl2, 4 Wg/ml
phosphoramidon, and 10 WM leupeptin in a total volume of 250 Wl.
200 pM of 125I-human galanin was used. Reactions were initiated by
the addition of membranes and the incubation was allowed to proceed
at room temperature for 2 h. Non-speci¢c binding was de¢ned as the
amount of radioactivity remaining bound in the presence of 10 WM
unlabeled human galanin. Incubations were terminated by rapid ¢l-
tration through GF/C ¢lters which had been presoaked with 0.1%
polyethylamine using a TOMTEC (Orange, CT) cell harvester.
3. Results and discussion
3.1. Cloning of GPR54
Based on sequence conservation of GPCR transmembrane
regions, we employed a degenerate PCR strategy to search for
novel genes and cDNAs encoding GPCRs. Two degenerate
primers P1 and P2, based on conserved GPCR sequences in
TM3 and TM7, respectively, were used to amplify human
genomic DNA and an aliquot of a rat brain cDNA library
with proofreading Pfu polymerase. Analysis of the PCR am-
pli¢cations followed by gel electrophoresis demonstrated a
strong ethidium bromide band of V500 bp long. The DNA
was excised, subcloned into the pBluescript vector, and se-
quenced to reveal a high level of GPCR ampli¢cation (Table
1). One of the resulting rat clones appeared to partially encode
a galanin/opioid-like receptor. The partial cDNA was labeled
with [32P]dCTP-K and used to screen the cDNA library em-
ployed in the degenerate PCR. Two positive plaques were
puri¢ed and their inserts ampli¢ed by PCR using Pfu poly-
merase and primers £anking the cloning site of the Vgt11
vector. The PCR products were subcloned into pBluescript
and sequenced. Sequence analysis revealed that each plaque
encoded a region of a putative GPCR from TM3 to the car-
boxy-terminus identical to each other and the original probe.
A second round of screening of 1U106 plaques freshly plated
from the same library yielded an additional three positive
plaques. PCR ampli¢cation of these positive plaques with
Vgt11 £anking primers, each paired with an internal primer,
revealed that only one of these positive plaques contained the
entire open reading frame (ORF). This plaque was puri¢ed,
the insert subcloned into pBluescript and was con¢rmed to
contain the 5P end of the full-length open reading frame. Fi-
nally, two speci¢c primers from the 5P and 3P ends of the ORF
were used to amplify with pfu polymerase the full length rat
cDNA 1.2 kb clone, named GPR54. Sequence analysis re-
vealed the cloned GPR54 ORF to be identical to the previous
phage clones and the original probe.
3.2. Sequence analysis of GPR54
GPR54 contained an ORF of 1191 bp encoding for a pro-
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Table 1
Classi¢cation of products from degenerate primer-based PCR
Receptor Rat whole brain cDNA Human genomic DNA Total
45‡C 42‡C 40‡C 55‡C 48‡C 45‡C 40‡C
Adenosine A2 0 1 0 0 0 0 0 1
Adrenergic K1 2 3 1 0 0 1 0 7
Adrenergic L3 0 0 0 0 1 0 0 1
Adrenomedullin 1 0 0 0 0 0 0 1
Cannabinoid 2 0 0 0 0 1 0 2 3
Chemokine CCR-6 0 0 0 1 1 0 0 2
Chemokine CCR-7 0 0 0 0 0 0 1 1
Chemokine CXCR-2 0 0 0 1 1 1 0 3
Chemokine CXCR-4 2 6 2 0 1 0 0 11
Dopamine D5 0 0 0 0 0 0 1 1
Histamine H2 0 1 0 0 0 0 0 1
Melanocortin 1 0 0 0 0 1 0 0 1
Olfactory 1 0 0 4 2 1 1 9
Purinoceptor P2U 0 0 0 0 0 0 1 1
Serotonin 5-HT5B 1 0 0 0 0 0 0 1
Somatostatin SSTR1 7 33 0 0 0 0 0 40
Somatostatin SSTR2 6 3 1 0 3 0 0 13
Somatostatin SSTR3 0 1 1 0 0 0 1 3
APJ 1 0 0 1 0 0 0 2
OGR1 1 0 0 2 1 0 0 4
RDC1 16 1 2 1 1 2 0 23
GPR3 2 0 0 0 1 1 0 4
GPR4 4 0 0 0 0 0 0 4
GPR5 0 0 0 0 2 4 0 6
GPR6 0 0 0 0 1 0 0 1
GPR7 0 1 0 2 0 0 1 4
GPR8 0 0 0 0 0 1 0 1
GPR9 0 0 0 1 0 0 0 1
GPR25 0 0 0 1 0 1 0 2
GPR30 0 0 0 0 0 1 0 1
GPR54 1 0 0 0 0 0 0 1
No GPCR homology 63 4 11 4 16 5 10 113
Total 108 54 18 18 33 18 18 267
A tally of genes encoding various GPCRs ampli¢ed by PCR using degenerate oligonucleotide primers with di¡erent template and annealing
temperature combinations. Our novel gene, GPR54, is shown in bold.
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tein of 396 amino acids (aa). Using GPR54 in a BLAST
search [17], the highest identity was observed with the galanin
and opioid receptor families. Speci¢cally, GPR54 shared an
amino acid sequence identity in the TM regions with rat gal-
anin receptors GalR1 (45%), GalR3 (45%), GalR2 (44%), and
rat opioid receptor DOR (37%) (Fig. 1). Conserved residues
and consensus sequences of the rhodopsin superfamily of
GPCRs present in GPR54 included an asparagine in TM1,
an aspartate in TM2, prolines in TMs 4^7, three consensus
sequences for N-linked glycosylation in the amino-terminus,
cysteines in the ¢rst and second extracellular loops, a PKA/
PKC consensus sequence in the second intracellular loop, a
PKC consensus sequence in the third intracellular loop and
three possible palmitoylation cysteine sites in the carboxy tail.
Signi¢cantly, various residues in the human GalR1 receptor
shown to be important for high a⁄nity galanin binding (cor-
responding to His-262, His-265, Glu-269, and Phe-280 in rat
GalR1 [18,19]) were not conserved in GPR54. Among these,
however, only His-262 is conserved among the three galanin
receptors. In addition, the substitution of a tyrosine residue
found in GPR54, GalR2 and GalR3 in place of Phe-280 in
GalR1 was shown to have no signi¢cant e¡ect on galanin
binding [19] as opposed to previous studies where Phe-280
was replaced by alanine in GalR1 [18].
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Fig. 2. Northern blot analysis of the tissue distribution of GPR54
mRNA in rat brain. Each lane contained 5 Wg of poly(A) RNA
isolated from various rat tissues.
Fig. 3. Dark¢eld autoradiograms of sagittal and coronal sections of rat brain showing the localization of GPR54 receptor mRNA. A: A lateral
representative section at 0.9 mm. Also shown are representitive sections at levels relative to the bregma at 33.3 mm (B), 33.8 mm (C) and
36.3 mm (D). Aco, cortical nucleus of the amygdala; AHy, anterior hypothalamic area; Arc, hypothalamic arcuate nucleus; IC, inferior colli-
culus; CA, ¢eld of Ammon’s horn; DG, dentate gyrus; DM, dorsomedial hypothalamic nucleus; LC, locus coeruleus; LH, lateral hypothala-
mic area; LHb, lateral habenular nucleus; MeA, medial nucleus of the amygdala; MPO, medial preoptic area; MRN, mesencephalic reticular
nucleus; PAG, periaqueductal gray; PB, parabrachial nucleus; PF, parafascicular thalamic nucleus; PH, posterior hypothalamic nucleus; PMV,
ventral premamillary nucleus; PO, primary olfactory cortex; RSpl, retrosplenial cortex; SC, superior colliculus; SHy, septohypothalamic nu-
cleus; VTA, ventral tegmental area; ZI, zona incerta.
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3.3. Tissue distribution
Both Northern blot and in situ hybridization analyses of
GPR54 were performed at high stringencies and with a DNA
probe encoding GPR54 from TM3 to TM7 and with low
identities to the genes encoding galanin and related receptors.
The tissue distribution of GPR54 was obtained by northern
blot analysis using poly(A) RNA isolated from various rat
tissues (Fig. 2). In the brain, multiple RNA transcripts with a
complex pattern were detected in the medulla pons, midbrain,
hippocampus, cortex, frontal cortex, and striatum. The most
intense band was approximately 3.7 kb in length, with a sin-
gle, larger transcript of approximately 12 kb length detected in
the liver and intestine only. No transcripts were revealed in
the cerebellum or kidney tissues. Future experiments will be
required to determine the reasons underlying the multiple
transcripts.
Using in situ hybridization of rat brain sections, the distri-
bution of GPR54 mRNA was found to be discretely localized
to many areas (Fig. 3). The highest levels of expression were
seen in hypothalamic and amygdaloid nuclei. GPR54 mRNA
was highly expressed in the zona incerta, ventral tegmental
area, dentate gyrus, hypothalamic arcuate nucleus, dorsome-
dial hypothalamic nucleus, primary olfactory cortex, lateral
habenular nucleus, lateral hypothalamic area, locus coeruleus,
and the cortical and medial nuclei of the amygdala. GPR54
mRNA was also concentrated in the superior colliculus, me-
dial preoptic area, anterior hypothalamic area, posterior hy-
pothalamic nucleus, periaqueductal gray, parafascicular thala-
mic nucleus, parabrachial nucleus, and ventral premamillary
nucleus. The signals detected in the septohypothalamic nu-
cleus, inferior colliculus, medial nucleus of the amygdala, mes-
encephalic reticular nucleus and retrosplenial cortex were dif-
fuse and less abundant.
GPR54’s CNS expression pattern was found to resemble
those of galanin receptors. Speci¢cally, rat GalR1 mRNA
expression is abundant in several brain regions including the
hypothalamus, amygdala, hippocampus and locus coeruleus
[20]. Rat GalR2 mRNA expression is found in the mamillary
nuclei, the dentate gyrus and posterior hypothalamic and arc-
uate nuclei [13]. Rat GalR3 is found to be abundantly ex-
pressed in the CA regions of Ammon’s horn and the dentate
gyrus with transcripts also detected in thalamic, hypothala-
mic, mamillary and amygdaloid nuclei [13].
3.4. Pharmacological characterization of the receptor encoded
by GPR54
The identity and overlapping expression patterns of GPR54
with the galanin receptors suggested that the encoded receptor
may demonstrate binding to galanin. In preparation for the
expression and binding studies, the 1.2 kb cDNA fragment
encoding the ORF of GPR54 was subcloned into the multiple
cloning site of the pcDNA3 expression vector and transiently
transfected into COS-7 cells. No speci¢c binding was observed
with 125I-human galanin. In contrast, speci¢c and high a⁄nity
binding was observed under similar conditions with 125I-hu-
man galanin in membranes prepared from COS cells trans-
fected with human GalR1, as well as in our previous report
for GalR2 and GalR3 [13].
3.5. Identi¢cation and chromosomal mapping of the human
orthologue of GPR54
A BLAST search with the rat GPR54 sequence revealed
high identity with a human 3.5 Mb contig located in chromo-
some 19p13.3 containing a serine protease gene cluster (Gen-
bank accession number AC005379). Sequence analysis re-
vealed a previously unrecognised 3.3 kb intron-containing
human orthologue of GPR54 encoding a protein 398 aa in
length and sharing a translated aa identity of 81% (100%
identity in the TM regions). The genomic sequence revealed
four introns located in TM2 (V800 bp, interrupting the trans-
lated FYI..ANL sequence), TM3 (V800 bp, interrupting
IQQ..VSV), TM4 (V250 bp, interrupting WVG..SAA) and
in the third intracellular loop (V180 bp, interrupting
ALQ..GQV).
In summary, we report the cloning and chromosomal local-
ization of a novel GPCR with complex and abundant CNS
and peripheral expression. While preliminary studies have not
shown speci¢c binding between GPR54 and galanin, sequence
identities and parallel distribution patterns between galanin
receptors with GPR54 suggest that GPR54’s endogenous li-
gand is peptidergic in nature.
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